Synta gets good news with lead cancer drug in blood cancer trial

An experimental drug by Synta Pharmaceuticals that has been in recent trials against lung, breast and ovarian cancer will move into a late-stage head-to-head test against other promising drugs to treat elderly patients with newly-diagnosed blood cancer...